InVitro Select is re-engineering the sperm selection process for assisted reproductive procedures such as In-Vitro Fertilization (IVF). Unfortunately, the average IVF cycle only leads to a successful pregnancy about 30% of the time and costs an average of $13,000 per attempt and is generally not covered by insurance. This results in debilitating costs for families both economically and psychologically. Unlike current sperm selection methods, InVitro Select’s methodology is based on the natural human fertilization process – enriching sperm in terms of speed (motility), shape (morphology), and a chemical attractant (chemotaxis) to increase the success of IVF by 10% or more (from 30% to 40%). This technology will not only temper the aforementioned burdens placed upon those undergoing IVF, but will also open the door for millions of couples battling infertility to afford the procedure by reducing the number of IVF attempts needed for a successful pregnancy.
Company’s Keywords:
healthcare, biotechnology, medical devices, fertility, life sciences, medical, health care
<2
<
<2015
Your request has been submitted successfully.
Own or work here?